 |
市場調查報告書
商品編碼
1863879
治療性血漿置換市場：按類型、產品類型、疾病適應症、手術類型、最終用戶和地區分類Therapeutic Plasma Exchange Market, By Type, By Product Type, By Disease Indication, By Procedure Type, By End User, By Geography |
||||||
預計到 2025 年，治療性血漿置換市場規模將達到 14.4 億美元，到 2032 年將達到 24.8 億美元，2025 年至 2032 年的複合年成長率為 8.1%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2024 | 2025年市場規模： | 14.4億美元 |
| 性能數據： | 2020年至2024年 | 預測期： | 2025年至2032年 |
| 預測期（2025-2032年）複合年成長率： | 8.10% | 2032年價值預測： | 24.8億美元 |
全球治療性血漿置換市場是更廣泛的血液淨化和分離術行業中的重要細分市場，涵蓋旨在治療各種自體免疫、神經系統疾病和血液系統疾病的先進醫療程序。
治療性血漿置換（也稱為血漿分離術）是指從患者血液中選擇性地去除血漿，並同時以捐贈者血漿、白蛋白或其他血漿代用品進行替換。這種先進的治療方法因其在治療重症肌無力、Guillain-Barré二氏症候群、血栓性血小板低下紫斑症和各種血管炎等疾病方面的有效性而備受認可。
該市場涵蓋了在醫院、專科護理中心和門診機構進行這些救生手術所需的專用醫療設備、耗材和服務。隨著全球醫療系統日益認知到血漿置換療法的治療益處，在技術進步、臨床應用拓展和患者療效改善的推動下，該市場正經歷顯著成長。
市場動態
全球治療性血漿置換市場的主要驅動力是全球自體免疫和神經系統疾病盛行率的不斷上升，從而產生了對專業血漿置換療法的巨大需求。此外，全球人口老化也是推動市場成長的重要因素，因為老年人更容易罹患需要接受治療性血漿置換療法的疾病。
血漿置換設備的科技進步，包括自動化和使用者友善系統的開發，正在提高該療法的效率和安全性，並促進其在醫療機構的更廣泛應用。血漿置換的臨床應用範圍已擴展到傳統適應症之外，這正在創造新的市場機遇，並且目前正在進行研究，以證明其在治療某些精神疾病和膿毒症相關併發症等新興疾病方面的有效性。
新興經濟體政府支持血液安全計畫和醫療基礎設施建設的措施也促進了市場擴張。然而，治療性血漿置換手術的高成本限制了低收入患者和資源匱乏的醫療機構獲得該服務的機會，對市場發展構成重大阻礙因素。
訓練有素、能夠執行複雜血漿分離術的醫護人員短缺也是一項重大挑戰，尤其是在發展中地區。此外，血漿衍生產品和器械核准流程的嚴格監管要求可能會延緩產品上市，並增加製造商的營運成本。儘管面臨這些挑戰，但仍存在一些機遇，例如開發攜帶式且經濟高效的血漿置換機、開拓服務不足的地區市場，以及透過臨床研究和開發舉措探索新的治療應用。
本次調查的主要特點
- 本報告對全球治療性血漿置換市場進行了詳細分析，以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和復合年成長率（%）。
- 它還指出了每個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 該報告根據以下參數對全球治療性血漿置換市場的主要企業進行了分析：公司概況、產品系列、主要特徵、財務表現和策略。
- 本報告的研究結果將使負責人和經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 本報告的目標受眾是全球治療性血漿置換市場的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過各種策略矩陣輕鬆做出決策，這些矩陣用於分析全球治療性血漿置換市場。
目錄
第1章：調查目標和前提條件
- 調查目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章：市場動態、監理及趨勢分析
- 市場動態
- 促進要素
- 抑制因素
- 機會
- 影響分析
- 重大進展
- 監管情景
- 產品發布/核准
- PEST分析
- 波特五力分析
- 併購情景
- 產業趨勢
4. 全球治療性血漿置換市場（按類型分類），2020-2032年
- 離心（間歇流和連續流）
- 薄膜過濾
5. 2020-2032年全球治療性血漿置換市場（依產品類型分類）
- 裝置
- 消耗品
- 軟體和服務
6. 2020-2032年全球治療性血漿置換市場（依疾病適應症分類）
- 神經系統疾病
- 腎臟疾病
- 血液疾病
- 代謝紊亂
- 其他跡象
7. 2020-2032年全球治療性血漿置換市場（依手術類型分類）
- 手動TPE
- 自動化TPE
- 雙重過濾血漿置換術（DFPP）
8. 2020-2032年全球治療性血漿置換市場（依最終使用者分類）
- 醫院
- 專科診所
- 門診手術中心
- 血液採集中心和血液成分供應商
- 輸血中心
9. 2020-2032年全球治療性血漿置換市場（按地區分類）
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中非
第10章 競爭格局
- Asahi Kasei Corporation
- Baxter International Inc.
- Braun Melsungen AG
- Cerus Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Haier Biomedical
- Isto Biologics
- Medica SpA
- Medicap Clinic GmbH
- Nikkiso Co., Ltd.
- SB-Kawasumi Laboratories, Inc.
- Terumo BCT, Inc.
- Zhengyuan Technology Co., Ltd.
- Grifols SA
第11章 分析師建議
- 機會
- 分析師觀點
- Coherent Opportunity Map
第12章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Therapeutic Plasma Exchange Market is estimated to be valued at USD 1.44 Bn in 2025 and is expected to reach USD 2.48 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 1.44 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.10% | 2032 Value Projection: | USD 2.48 Bn |
The global therapeutic plasma exchange market represents a critical segment within the broader blood purification and apheresis industry, encompassing advanced medical procedures designed to treat various autoimmune, neurological, and hematological disorders.
Therapeutic plasma exchange, also known as plasmapheresis, involves the selective removal of plasma from a patient's blood while simultaneously replacing it with donor plasma, albumin, or other plasma substitutes. This sophisticated treatment modality has gained significant recognition for its efficacy in managing conditions such as myasthenia gravis, Guillain-Barre syndrome, thrombotic thrombocytopenic purpura, and various forms of vasculitis.
The market encompasses specialized medical equipment, consumables, and services required to perform these life-saving procedures across hospitals, specialized treatment centers, and outpatient facilities. As healthcare systems worldwide increasingly recognize the therapeutic benefits of plasma exchange procedures, the market has witnessed substantial growth driven by technological advancements, expanding clinical applications, and improved patient outcomes.
Market Dynamics
The global therapeutic plasma exchange market is primarily driven by the increasing prevalence of autoimmune and neurological disorders worldwide, creating substantial demand for specialized plasma exchange procedures. The aging global population has contributed significantly to market growth, as elderly individuals are more susceptible to conditions requiring therapeutic plasma exchange interventions.
Technological advancements in apheresis equipment, including the development of automated and user-friendly systems, have enhanced procedure efficiency and safety, thereby encouraging broader adoption across healthcare facilities. The expanding clinical applications of plasma exchange therapy beyond traditional indications have opened new market opportunities, with ongoing research demonstrating efficacy in treating emerging conditions such as certain psychiatric disorders and sepsis-related complications.
Government initiatives supporting blood safety programs and healthcare infrastructure development in emerging economies have further accelerated market expansion. However, the market faces significant restraints including the high cost of therapeutic plasma exchange procedures, which limits accessibility for patients without adequate insurance coverage or in resource-constrained healthcare settings.
The shortage of trained healthcare professionals capable of performing complex apheresis procedures poses another substantial challenge, particularly in developing regions. Additionally, stringent regulatory requirements for plasma-derived products and equipment approval processes can delay market entry and increase operational costs for manufacturers. Despite these challenges, opportunities exist in the development of portable and cost-effective plasma exchange devices, expansion into underserved geographic markets, and the exploration of novel therapeutic applications through clinical research and development initiatives.
Key Features of the Study
- This report provides in-depth analysis of the global therapeutic plasma exchange market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global therapeutic plasma exchange market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include leading manufacturers and service providers in the therapeutic plasma exchange industry
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global therapeutic plasma exchange market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global therapeutic plasma exchange market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Centrifugation (Intermittent and Continuous Flow Centrifugation)
- Membrane Filtration
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Devices
- Consumables
- Software and Services
- Disease Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Neurological Disorders
- Guillain-Barre syndrome
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Myasthenia gravis
- Multiple sclerosis
- Neuromyelitis optica
- Renal Disorders
- Anti-GBM disease
- Post-renal transplant rejection
- Wegener's granulomatosis
- Hematology Disorders
- Thrombotic thrombocytopenic purpura (TTP)
- Hemolytic uremic syndrome (HUS)
- Cryoglobulinemia
- Multiple myeloma
- Metabolic Disorders
- Homozygous familial hypercholesterolemia
- Fulminant Wilson's disease
- Other Indications
- Autoimmune diseases (e.g., systemic lupus erythematosus)
- Inflammatory disorders
- Procedure Type Insights (Revenue, USD Bn, 2020 - 2032)
- Manual TPE
- Automated TPE
- Double Filtered Plasmapheresis (DFPP)
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Blood Collection Centers and Blood Component Providers
- Transfusion Centers
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Asahi Kasei Corporation
- Baxter International Inc.
- Braun Melsungen AG
- Cerus Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Haier Biomedical
- Isto Biologics
- Medica S.p.A.
- Medicap Clinic GmbH
- Nikkiso Co., Ltd.
- SB-Kawasumi Laboratories, Inc.
- Terumo BCT, Inc.
- Zhengyuan Technology Co., Ltd.
- Grifols S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Therapeutic Plasma Exchange Market, By Type
- Global Therapeutic Plasma Exchange Market, By Product Type
- Global Therapeutic Plasma Exchange Market, By Disease Indication
- Global Therapeutic Plasma Exchange Market, By Procedure Type
- Global Therapeutic Plasma Exchange Market, By End User
- Global Therapeutic Plasma Exchange Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Therapeutic Plasma Exchange Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Centrifugation (Intermittent and Continuous Flow Centrifugation)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Membrane Filtration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Therapeutic Plasma Exchange Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Therapeutic Plasma Exchange Market, By Disease Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Guillain-Barre syndrome
- Chronic inflammatory demyelinating polyneuropathy (CIDP)
- Myasthenia gravis
- Multiple sclerosis
- Neuromyelitis optica
- Renal Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Anti-GBM disease
- Post-renal transplant rejection
- Wegener's granulomatosis
- Hematology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Thrombotic thrombocytopenic purpura (TTP)
- Hemolytic uremic syndrome (HUS)
- Cryoglobulinemia
- Multiple myeloma
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homozygous familial hypercholesterolemia
- Fulminant Wilson's disease
- Other Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune diseases (e.g., systemic lupus erythematosus)
- Inflammatory disorders
7. Global Therapeutic Plasma Exchange Market, By Procedure Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Manual TPE
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Automated TPE
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Double Filtered Plasmapheresis (DFPP)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Therapeutic Plasma Exchange Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Blood Collection Centers and Blood Component Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Transfusion Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Therapeutic Plasma Exchange Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Procedure Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Asahi Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cerus Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius Kabi AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Haemonetics Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Haier Biomedical
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Isto Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medica S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medicap Clinic GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Nikkiso Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SB-Kawasumi Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo BCT, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zhengyuan Technology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grifols S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
治療性血漿置換市場：按應用、手術類型、產品類型和最終用戶分類－2025-2032年全球預測
2025年全球治療性血漿置換市場報告
治療性血漿置換市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、技術、適應症、最終用戶、地區和競爭細分，2020 年至 2030 年）
全球治療性血漿置換市場規模（依適應症、最終用戶、區域範圍和預測）
全球治療性血漿交換市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測治療性血漿交換市場（疾病適應症：神經疾病、腎臟疾病、血液疾病、代謝障礙等）- 全球產業分析、規模、佔有率、數量、成長、趨勢和預測，2023-2031 年